July 24, 2007 (Lakeland, FL) - Neurognostics, a Milwaukee-based medical imaging company, has signed an agreement with Dr. Steven J. Porter, Psy.D., and Dr. Tracey G. Henley, Psy.D., of Psychological and Neurobehavioral Services, P.A., for the purchase and installation of the MindState fDAD Functional MR Imaging (fMRI) suite of products and services, and the creation of a paradigm-specific normative fMRI database for improved Central Nervous System (CNS) disorder detection and treatment.
"We are extremely excited to be working with Neurognostics to expand the capabilities of functional MRI," says Dr. Steven Porter, Psy.D. "By creating a functional imaging database of healthy individuals, we will gain clinical insights into the functionality differences of patients with neurodegenerative and/or neuropsychological disorders like Parkinson's disease, Alzheimer's, Dementia, and ADHD."
Functional MR imaging has the potential to dramatically increase our knowledge of debilitating CNS disorders. Because fMRI is a non-invasive alternative for clinicians and researchers to study brain function, multiple tests can easily be performed to track disease progression or evaluate the efficacy of therapeutic interventions. By simplifying the administration of an fMRI exam, Neurognostics also provides physicians with a reliable and cost effective way to provide their patients with the best possible imaging options.
"It is truly rewarding to be working with doctors who are so dedicated to improving clinical insights into CNS disorder detection and management" says Cathy Elsinger, Vice President of Research and Clinical Operations at Neurognostics. "By partnering with Dr. Porter and Dr. Henley, we can expand our research capabilities and clinical products to improve the quality of life for patients suffering from these neurodegenerative disorders."
About Neurognostics, Inc.
Neurognostics is a leading provider of integrated Functional MR Imaging (fMRI) solutions. fMRI is a powerful imaging technique that extends the capability of Magnetic Resonance Imaging (MRI) by providing information about the functionality of imaged brain tissue. Neurognostics has applied over a decade of research to standardize fMRI technology and extend its use in a variety of clinical settings. The Neurognostics integrated fMRI system supplies health care providers with state of the art functional imaging technology; integrating easily with existing devices and simplifying the application of fMRI.